Chairman of the Committee for Pro-Life Activities at america Conference of Catholic Bishops.

Ian Wilmut, head of the team that cloned ‘Dolly’ the sheep, now says he’s abandoning efforts at human ‘therapeutic cloning’ to pursue this adult cell reprogramming avenue instead, because it is superior as well as ‘easier to accept socially technically.’ I am grateful today for scientists who took up the task of finding morally acceptable methods to pursue stem cell analysis, and for federal government leaders who’ve funded and encouraged such avenues. This advance reminds us once again that medical progress and respect for human life are not in conflict; they can and really should support and enrich each other for the good of all. .. Advancing stem cell research and therapies while respecting the dignity of individual life fully The following statement was released by Cardinal Justin Rigali of Philadelphia, chairman of the Committee for Pro-Life Activities at america Conference of Catholic Bishops.Two sufferers in the rituximab group received a third dosage of cyclophosphamide: one was categorized as having a treatment failure; the other, who had a response to the rituximab routine and received the third cyclophosphamide dosage in violation of the process, was classified as having successful treatment. Main Outcomes Sustained Remission Sustained remission occurred in 25 of 33 individuals in the rituximab group and 9 of 11 sufferers in the control group .68). Six patients in the rituximab group and 1 affected person in the control group died within the first 12 weeks. Among the individuals who survived, 93 percent of the sufferers in the rituximab group and 90 percent of the individuals in the control group experienced sustained remission .